Nav: Home

Current Amyotrophic lateral sclerosis News and Events

Current Amyotrophic lateral sclerosis News and Events, Amyotrophic lateral sclerosis News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Unique case of cannabis hyperemesis syndrome in palliative care
The medical use of cannabis is growing. Medical marijuana may improve symptoms including pain and anorexia. (2019-06-10)
Foraging for nitrogen
As sessile organisms, plants rely on their ability to adapt the development and growth of their roots in response to changing nutrient conditions. (2019-06-07)
Scientists recreate blood-brain barrier defect outside the body
Scientists can't make a living copy of your brain outside your body. (2019-06-06)
Obesity worsens disability in multiple sclerosis
Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease. (2019-06-05)
Nanotechnology treatment shows promise against multiple sclerosis
A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by University of California, Irvine researchers. (2019-06-05)
Deletion in mouse neutrophils offers clues to pathogenesis in multiple sclerosis
A mouse model called experimental autoimmune encephalomyelitis, or EAE, is used to discover disease mechanisms that may translate into treatments for patients with multiple sclerosis. (2019-05-24)
ALS research reveals new treatment approach
New research on amyotrophic lateral sclerosis (AML) has revealed that a protein called membralin plays a key role in the disease process. (2019-05-23)
Global agreement reached on standards for clinical trials in children with MS
The International Pediatric MS Study Group -- a group of care providers and researchers looking to optimize worldwide care, education and research in pediatric multiple sclerosis -- was convened with sponsorship by the National MS Society and the MS Society of Canada. (2019-05-21)
Tumor-suppressing protein may be novel target in PAH therapy
In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH). (2019-05-19)
How stressed-out bacteria may trigger autoimmune response
Stressful life events most likely contribute to autoimmune diseases, but scientists don't have a deep understanding of the underlying chain of events. (2019-05-14)
Multiple sclerosis: Discovery of a mechanism responsible for chronic inflammation
Multiple sclerosis (MS) is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known. (2019-05-10)
Stem cells provide information about neuron resilience in ALS
Researchers at Karolinska Institutet in Sweden have developed a stem cell based model in order to study the resilience and vulnerability of neurons in the neurodegenerative disease ALS. (2019-05-09)
Fooling nerve cells into acting normal
In a new study, scientists at the University of Missouri have discovered that a neuron's own electrical signal, or voltage, can indicate whether the neuron is functioning normally. (2019-05-09)
A new culprit for multiple sclerosis relapses
A molecule that helps blood clot may also play a role in multiple sclerosis relapses, researchers report in the May 6, 2019 issue of PNAS. (2019-05-07)
Pigment-producing stem cells can regenerate vital part of nervous system
Neurodegenerative diseases like multiple sclerosis (MS) affect millions of people worldwide and occur when parts of the nervous system lose function over time. (2019-05-06)
Pluripotency or differentiation -- That is the question
Induced pluripotent stem cells can turn into any type of cell in the body or remain in their original form. (2019-05-02)
Out-of-pocket costs for neurologic medications rise sharply over 12 years
The amount of money people pay out-of-pocket for drugs to treat neurologic conditions like multiple sclerosis, dementia and Parkinson's disease has risen sharply over 12 years, with the most dramatic increase for multiple sclerosis (MS) medications, according to a study published in the May 1, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology. (2019-05-01)
Experimental drug shows promise for genetic form of ALS
An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental drug and, in exploratory results, the experimental drug was linked to possible slower progression in people with a genetic form of the disease caused by mutations in a gene called superoxide dismutase 1 (SOD1). (2019-05-01)
Guidelines proposed for newly defined Alzheimer's-like brain disorder
A recently recognized brain disorder called limbic-predominant age-related TDP-43 encephalopathy, or LATE, mimics clinical features of Alzheimer's disease. (2019-04-30)
Researchers define Alzheimer's-like brain disorder
Researchers at Rush University Medical Center and scientists from several National Institutes of Health-funded institutions, in collaboration with international peers, described the newly-named pathway to dementia, Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, in a report published today in the journal Brain. (2019-04-30)
Growing up in poverty increases diagnoses of psychosis-spectrum mental illnesses
Growing up in impoverished urban neighborhoods more than doubles your chances over the average person of developing a psychosis-spectrum disorder by the time you reach middle adulthood, according to a new UC Davis and Concordia University study of nearly 4,000 families who were monitored over 30 years. (2019-04-24)
Synthetic speech generated from brain recordings
A state-of-the-art brain-machine interface created by UC San Francisco neuroscientists can generate natural-sounding synthetic speech by using brain activity to control a virtual vocal tract -- an anatomically detailed computer simulation including the lips, jaw, tongue, and larynx. (2019-04-24)
A new clue in the mystery of ALS, frontotemporal dementia
Michigan Medicine (University of Michigan) researchers identify a potential therapeutic target for neurodegenerative conditions ALS and frontotemporal dementia, using animal models. (2019-04-23)
Study shows promise in repairing damaged myelin
A new study shows that a synthetic molecule developed by Oregon Health & Science University scientists stimulates repair of the protective sheath that covers nerve cells in the brain and spinal cord. (2019-04-18)
Vitamin D study sheds light on immune system effects
Scientists at the University of Edinburgh have uncovered fresh insights into how vitamin D affects the immune system and might influence susceptibility to diseases such as multiple sclerosis. (2019-04-17)
Measuring brain activity in milliseconds possible through new research
Researchers from King's College London, Harvard and INSERM-Paris have discovered a new way to measure brain function in milliseconds using magnetic resonance elastography (MRE). (2019-04-17)
What happens in the bodies of ALS patients?
Lara Marrone and Jared Sterneckert from the Centre for Regenerative Therapies Dresden (CRTD) at Technische Universit├Ąt Dresden (TUD), together with collaborating scientists from Germany, Italy, the Netherlands, and the USA, have now discovered that interactions between RNA-binding proteins are more critical to ALS pathogenesis than previously thought. (2019-04-15)
Knowing how cells grow and divide can lead to more robust and productive plants
In contrast to mammals, where the body plan is final at birth, the formation of new root branches ensures that the root system keeps growing throughout a plant's life. (2019-04-12)
Biochemical switches identified that could be triggered to treat muscle, brain disorders
St. Jude Children's Research Hospital scientists have found that the enzymes ULK1 and ULK2 play a key role in breaking down cell structures called stress granules, whose persistence leads to toxic buildup of proteins that kill muscle and brain cells. (2019-04-10)
Research reveals how the most common ALS mutation dooms cells
St. Jude Children's Research Hospital scientists have cracked the mystery surrounding the most common genetic cause of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. (2019-04-10)
Researchers reveal novel therapeutic strategy for ALS
Researchers from the Institute of Neuroscience and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis (ALS), suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS. (2019-04-09)
Study of multiple sclerosis patients shows 18 percent misdiagnosed
A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before being referred to two major Los Angeles medical centers for treatment actually had been misdiagnosed with the autoimmune disease. (2019-04-08)
Study: Protein key to charcot-marie-tooth, other nerve diseases
A new study provides critical insight into a little-known, yet relatively common, inherited neurological condition called Charcot-Marie-Tooth disease. (2019-04-04)
New ALS gene expression atlas offers unprecedented detail into disease progression
ALS researchers at the New York Genome Center have utilized new technologies for mapping gene expression in spinal cord samples that provide new insights into the mechanisms that contribute to disease onset and progression in ALS patients. (2019-04-04)
How ALS progresses on genetic and cellular level revealed by high-res spinal cord study
Precise experiments have revealed for the first time how Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), progresses on a genetic and cellular level. (2019-04-04)
Blocking protein's activity restores cognition in old mice, Stanford study shows
By blocking a protein's activity with antibodies, Stanford University School of Medicine investigators were able to improve cognitive behavior in aging mice. (2019-04-03)
Do minerals play a role in development of multiple sclerosis?
Some studies have suggested that minerals such as zinc and iron may play a role in how multiple sclerosis (MS) progresses, once people have been diagnosed with it. (2019-04-03)
Transplanted bone marrow endothelial progenitor cells delay ALS disease progression
Transplanting human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier, University of South Florida researchers report. (2019-04-02)
Anti-evolvability drugs could slow antibiotic resistance in bacteria
In a study publishing April 1, 2019 in the journal Molecular Cell, researchers found that one mechanism by which antibiotics induce drug-resistance mutations in bacteria is by triggering the generation of high levels of toxic molecules called reactive oxygen species (ROS). (2019-04-01)
Novel strategy fights back bacterial antibiotic resistance
A new strategy to combat antibiotic resistance has emerged from a study led by researchers at Baylor College of Medicine. (2019-04-01)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...